Despite significant advancements, challenges remain. One major issue is the cost of treatments, which can be prohibitively expensive for many patients. Additionally, while new therapies show promise, they may not be effective for all patients, highlighting the need for further research. There is also the challenge of drug resistance, where cancer cells adapt to become resistant to treatments, necessitating the development of new therapeutic strategies.
